185 related articles for article (PubMed ID: 32330381)
61. Sequential-targeting nanocarriers with pH-controlled charge reversal for enhanced mitochondria-located photodynamic-immunotherapy of cancer.
Peng N; Yu H; Yu W; Yang M; Chen H; Zou T; Deng K; Huang S; Liu Y
Acta Biomater; 2020 Mar; 105():223-238. PubMed ID: 31926335
[TBL] [Abstract][Full Text] [Related]
62. Preclinical study of Ublituximab, a Glycoengineered anti-human CD20 antibody, in murine models of primary cerebral and intraocular B-cell lymphomas.
Ben Abdelwahed R; Donnou S; Ouakrim H; Crozet L; Cosette J; Jacquet A; Tourais I; Fournès B; Gillard Bocquet M; Miloudi A; Touitou V; Daussy C; Naud MC; Fridman WH; Sautès-Fridman C; Urbain R; Fisson S
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3657-65. PubMed ID: 23611989
[TBL] [Abstract][Full Text] [Related]
63. Elucidating the Drug Release from Metal-Organic Framework Nanocomposites via In Situ Synchrotron Microspectroscopy and Theoretical Modeling.
Souza BE; Donà L; Titov K; Bruzzese P; Zeng Z; Zhang Y; Babal AS; Möslein AF; Frogley MD; Wolna M; Cinque G; Civalleri B; Tan JC
ACS Appl Mater Interfaces; 2020 Jan; 12(4):5147-5156. PubMed ID: 31904920
[TBL] [Abstract][Full Text] [Related]
64. Folic Acid Functionalized Zirconium-Based Metal-Organic Frameworks as Drug Carriers for Active Tumor-Targeted Drug Delivery.
Dong H; Yang GX; Zhang X; Meng XB; Sheng JL; Sun XJ; Feng YJ; Zhang FM
Chemistry; 2018 Nov; 24(64):17148-17154. PubMed ID: 30125400
[TBL] [Abstract][Full Text] [Related]
65. Click-Nucleic-Acid-Containing Codelivery System Inducing Collapse of Cellular Homeostasis for Tumor Therapy through Bidirectional Regulation of Autophagy and Glycolysis.
Guo Q; Chen Q; Zhang Y; Zhou W; Li X; Li C; Zhang Y; Chen H; Liu P; Chu Y; Sun T; Jiang C
ACS Appl Mater Interfaces; 2020 Dec; 12(52):57757-57767. PubMed ID: 33319976
[TBL] [Abstract][Full Text] [Related]
66. Gambogic acid induces apoptosis and inhibits colorectal tumor growth via mitochondrial pathways.
Huang GM; Sun Y; Ge X; Wan X; Li CB
World J Gastroenterol; 2015 May; 21(20):6194-205. PubMed ID: 26034354
[TBL] [Abstract][Full Text] [Related]
67. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
[TBL] [Abstract][Full Text] [Related]
68. Fabrication of a new superparamagnetic metal-organic framework with core-shell nanocomposite structures: Characterization, biocompatibility, and drug release study.
Ebrahimi AK; Barani M; Sheikhshoaie I
Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():349-355. PubMed ID: 30184760
[TBL] [Abstract][Full Text] [Related]
69. Cell Membrane Capsules for Encapsulation of Chemotherapeutic and Cancer Cell Targeting in Vivo.
Peng LH; Zhang YH; Han LJ; Zhang CZ; Wu JH; Wang XR; Gao JQ; Mao ZW
ACS Appl Mater Interfaces; 2015 Aug; 7(33):18628-37. PubMed ID: 26262951
[TBL] [Abstract][Full Text] [Related]
70. Ginsenoside Rh4 suppresses aerobic glycolysis and the expression of PD-L1 via targeting AKT in esophageal cancer.
Deng X; Zhao J; Qu L; Duan Z; Fu R; Zhu C; Fan D
Biochem Pharmacol; 2020 Aug; 178():114038. PubMed ID: 32422139
[TBL] [Abstract][Full Text] [Related]
71. Smart pH-Sensitive Nanogels for Enhancing Synergistic Anticancer Effects of Integrin α
Xu Y; Sun L; Feng S; Chen J; Gao Y; Guo L; An X; Nie Y; Zhang Y; Liu X; Ning X
ACS Appl Mater Interfaces; 2019 Sep; 11(38):34663-34675. PubMed ID: 31490654
[TBL] [Abstract][Full Text] [Related]
72. Macrophage membrane coated persistent luminescence nanoparticle@MOF-derived mesoporous carbon core-shell nanocomposites for autofluorescence-free imaging-guided chemotherapy.
Chen LJ; Zhao X; Liu YY; Yan XP
J Mater Chem B; 2020 Sep; 8(35):8071-8083. PubMed ID: 32785386
[TBL] [Abstract][Full Text] [Related]
73. Aptamer-guided nanomedicines for anticancer drug delivery.
Alshaer W; Hillaireau H; Fattal E
Adv Drug Deliv Rev; 2018 Sep; 134():122-137. PubMed ID: 30267743
[TBL] [Abstract][Full Text] [Related]
74. Mitocans: mitochondrial targeted anti-cancer drugs as improved therapies and related patent documents.
Ralph SJ; Low P; Dong L; Lawen A; Neuzil J
Recent Pat Anticancer Drug Discov; 2006 Nov; 1(3):327-46. PubMed ID: 18221044
[TBL] [Abstract][Full Text] [Related]
75. Selective apoptotic killing of solid and hematologic tumor cells by bombesin-targeted delivery of mitochondria-disrupting peptides.
Cai H; Yang H; Xiang B; Li S; Liu S; Wan L; Zhang J; Li Y; Cheng J; Lu X
Mol Pharm; 2010 Apr; 7(2):586-96. PubMed ID: 20141196
[TBL] [Abstract][Full Text] [Related]
76. Epigenetic Regulation of Bmi1 by Ubiquitination and Proteasomal Degradation Inhibit Bcl-2 in Acute Myeloid Leukemia.
Kushwaha AC; Mohanbhai SJ; Sardoiwala MN; Sood A; Karmakar S; Roy Choudhury S
ACS Appl Mater Interfaces; 2020 Jun; 12(23):25633-25644. PubMed ID: 32453568
[TBL] [Abstract][Full Text] [Related]
77. ZD2-Engineered Gold Nanostar@Metal-Organic Framework Nanoprobes for T
Zhang L; Liu C; Gao Y; Li Z; Xing J; Ren W; Zhang L; Li A; Lu G; Wu A; Zeng L
Adv Healthc Mater; 2018 Dec; 7(24):e1801144. PubMed ID: 30370656
[TBL] [Abstract][Full Text] [Related]
78. Erythrocyte Membrane-Camouflaged IR780 and DTX Coloading Polymeric Nanoparticles for Imaging-Guided Cancer Photo-Chemo Combination Therapy.
Yang Q; Xiao Y; Yin Y; Li G; Peng J
Mol Pharm; 2019 Jul; 16(7):3208-3220. PubMed ID: 31145853
[TBL] [Abstract][Full Text] [Related]
79. Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance.
Wang H; Yin H; Yan F; Sun M; Du L; Peng W; Li Q; Feng Y; Zhou Y
Oncotarget; 2015 Feb; 6(5):2827-42. PubMed ID: 25605018
[TBL] [Abstract][Full Text] [Related]
80. The synergistic effect of PFK15 with metformin exerts anti-myeloma activity via PFKFB3.
Liu X; Zhao Y; Zhang E; Yan H; Lv N; Cai Z
Biochem Biophys Res Commun; 2019 Jul; 515(2):332-338. PubMed ID: 31153642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
